Vanda Pharmaceuticals
VNDA
#8694
Rank
S$0.31 B
Marketcap
S$5.23
Share price
7.07%
Change (1 day)
-9.00%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -S$0.24 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are S$0.21 Billion. In 2025 the company made an earning of -S$0.2 Billion a decrease over its 2024 earnings that were of -S$52.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.24 Billion23.69%
2025 -S$0.2 Billion271.79%
2024 -S$52.03 Million191.43%
2023 -S$17.86 Million-320.45%
2022 S$8.09 M-84.99%
2021 S$53.95 M54.8%
2020 S$34.85 M19.42%
2019 S$29.18 M4.93%
2018 S$27.81 M-228.6%
2017 -S$21.63 Million-8.98%
2016 -S$23.77 Million-53.79%
2015 -S$51.43 Million-30.18%
2014 -S$73.65 Million173.08%
2013 -S$26.97 Million-25.33%
2012 -S$36.12 Million163.61%
2011 -S$13.71 Million-221.15%
2010 S$11.3 M-124.53%
2009 -S$46.11 Million-29.44%
2008 -S$65.35 Million-36.2%
2007 -S$0.11 Billion21.81%
2006 -S$84.09 Million170.55%
2005 -S$31.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$23.95 B-10,182.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$16.17 B-6,909.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$8.83 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.49 B-18,826.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.50 B-6,203.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-S$3.59 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA